title: Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension.
authors.affiliation: Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, CT 06030-3940, USA. wwhite@nso1.uchc.edu
authors.forename: William B
authors.initials: WB
authors.lastname: White
authors.forename: Robert
authors.initials: R
authors.lastname: Bresalier
authors.forename: Allen P
authors.initials: AP
authors.lastname: Kaplan
authors.forename: Biff F
authors.initials: BF
authors.lastname: Palmer
authors.forename: Robert H
authors.initials: RH
authors.lastname: Riddell
authors.forename: Anastasia
authors.initials: A
authors.lastname: Lesogor
authors.forename: William
authors.initials: W
authors.lastname: Chang
authors.forename: Deborah L
authors.initials: DL
authors.lastname: Keefe
mesh_terms: D000368:Aged; D000577:Amides / Q000009:adverse effects* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005650:Fumarates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012084:Renin-Angiotensin System / Q000187:drug effects; D012306:Risk; D000092502:Renin Inhibitors
chemical_list: D000577:Amides; D000959:Antihypertensive Agents; D005650:Fumarates; D000092502:Renin Inhibitors; C446481:aliskiren